Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brazil regional study of treatment for chronic Chagas disease with cardiac involvement
RBR-973pt5nPhase 2Not yet recruiting
- Sponsor
- Evandro Chagas National Institute of Infectology
- Start
- Aug 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in American trypanosomiasis (CD) comparing Benznidazole observational multicenter arm, Montes Claros placebo control arm and Montes Claros nifurtimox experimental arm (3 arms). Planned start Aug 2023; status: not yet recruiting.
02
Drugs
benznidazolenifurtimox
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on RBR-973pt5n.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-973pt5n.